egnite Launches New Lp(a) Identification Capability to Accelerate Clinical Trial Enrollment

▤ Summary

egnite added a new Lp(a) patient identification module to its CardioCare Research Suite. The capability helps health systems and research teams find patients with elevated Lp(a) levels who may qualify for clinical trials. The company says the module can uncover previously undetected patient populations and speed trial enrollment. The launch extends egnite's cardiovascular intelligence platform for care delivery and life sciences research workflows.

▦ Linked Companies

egnite, Inc.

$10M to $25M